Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractThe last decades of Nobel prize-honored research have unequivocally proven a key role of dendritic cells (DCs) at controlling both T cell immunity and tolerance. A tight balance between these opposing DC functions ensures immune homeostasis and host integrity. Its perturbation could explain pathological conditions such as the attack of self tissues, chronic infections, and tumor immune evasion. While recent insights into the complex DC network help to understand the contribution of individual DC subsets to immunity, the tolerogenic functions of DCs only begin to emerge. As these consist of many different layers, the definition of a "tolerogenic DC" is subjected to variation. Moreover, the implication of DCs and DC subsets in the suppression of autoimmunity are incompletely resolved. In this review, we point out conceptual controversies and dissect the various layers of DC-mediated T cell tolerance. These layers include central tolerance, Foxp3(+) regulatory T cells (Tregs), anergy/deletion and negative feedback regulation. The mode and kinetics of antigen presentation is highlighted as an additional factor shaping tolerance. Special emphasis is given to the interaction between layers of tolerance as well as their differential regulation during inflammation. Furthermore, potential technical caveats of DC depletion models are considered. Finally, we summarize our current understanding of DC-mediated tolerance and its role for the suppression of autoimmunity. Understanding the mechanisms of DC-mediated tolerance and their complex interplay is fundamental for the development of selective therapeutic strategies, e.g., for the modulation of autoimmune responses or for the immunotherapy of cancer.
CitationLayers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity. 2012, 3:183 Front Immunol
AffiliationInstitute of Infection Immunology, TWINCORE/Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Straβe7, 30625 Hannover, Germany.
JournalFrontiers in immunology
The following license files are associated with this item:
- Functional crosstalk between dendritic cells and Foxp3(+) regulatory T cells in the maintenance of immune tolerance.
- Authors: Kornete M, Piccirillo CA
- Issue date: 2012
- Dendritic cells and T cells in the regulation of cutaneous immunity.
- Authors: Loser K, Beissert S
- Issue date: 2007
- The benefits of diversity: heterogenous DC populations allow for both immunity and tolerance.
- Authors: Moore JR
- Issue date: 2014 Sep 21
- Dendritic cell vaccine design: strategies for eliciting peripheral tolerance as therapy of autoimmune diseases.
- Authors: Xiao BG, Huang YM, Link H
- Issue date: 2003
- CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
- Authors: Pellegrini P, Totaro R, Contasta I, Berghella AM, Carolei A, Adorno D
- Issue date: 2005